Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We have previously defined factors that predict the long term success of maintenance CsA monotherapy (CsAm) after kidney transplantation : donor age < 40 years, serum creatinine level at the initiation of CsAm £ 125 µmol/L, no rejection episode before CsAm initiation. We have also shown that the 8-year graft survival in 329 selected patients enrolled in maintenance CsA-m was 84 % (Hurault de Ligny et al, Transplantation, 2000 ; 69 : 1327-1332). These results were obtained with an old formulation of cyclosporin, azathioprine, steroid withdrawal over the first year and induction antibody. This prospective randomized multicentre study was designed to clarify whether maintenance Neoral + MMF or Neoral + AZA is better than a CsAm and wether Neoral + MMF is better than Neoral + AZA in low immunological risk cadaveric kidney transplant recipients.
Between july 1998 and january 2004 selected patients were randomly assigned equally within each centre to receive CsAm or bitherapy with equally CsA + MMF or CsA + AZA.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cyclosporin A: C0: 75-125ng/ml-dose adapted in the 3 groups | Drug | |||
| Group A: CsA + Azathioprine(1 to 2 mg/kg/day) | Drug | |||
| Group B: CsA + CellCept(500 mg x 2/day) | Drug | |||
| Group C: CsAm | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| to compare maintenance CsAm with dual therapy groups and within dual therapy MMF with AZA for : | ||
| The incidence and the delay of occurrence of graft dysfunction episode defined as ³ 20 % increase in serum creatinine level (mean of three results obtained in the same laboratory) and requiring a graft biopsy. | ||
| Causes of graft dysfunction episodes diagnosed by graft biopsy. | ||
| The incidence of serious infections (HVZ, EBV, HPV genital infection, febrile UTI, pneumonitis...) |
| Measure | Description | Time Frame |
|---|---|---|
| To compare the three treatment groups for the following parameters : | ||
| Incidence of therapeutic failure defined by biopsy proven acute rejection episode or CsA renal toxicity | ||
Not provided
Inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| TOUCHARD Guy, MD,Professor | Poitiers University Hospital, POITIERS, 86021, FRANCE | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Caen university Hospital | Caen | 14033 | France | |||
| Dupuytren University Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 10798748 | Background | Hurault de Ligny B, Toupance O, Lavaud S, Bauwens M, Peyronnet P, Le Meur Y, Ryckelynck JP, Jolly D, Leroux-Robert C, Touchard G. Factors predicting the long-term success of maintenance cyclosporine monotherapy after kidney transplantation. Transplantation. 2000 Apr 15;69(7):1327-32. doi: 10.1097/00007890-200004150-00019. | |
| 9306349 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Graft function evaluated by serum creatinine level and calculated creatinine clearance (CG formula) |
| Adverse events |
| Patient and graft survival |
| Limoges |
| 87042 |
| France |
| Poitiers University hospital | Poitiers | 86021 | France |
| Reims University Hospital | Reims | 51092 | France |
| Rouen University Hospital | Rouen | 76031 | France |
| Touchard G, Hauet T, Cogny Van Weydevelt F, Hurault de Ligny B, Peyronnet P, Lebranchu Y, Toupance O, N'Doye P, Busson M. Maintenance cyclosporin monotherapy after renal transplantation--clinical predictors of long-term outcome. Nephrol Dial Transplant. 1997 Sep;12(9):1956-60. doi: 10.1093/ndt/12.9.1956. |
| ID | Term |
|---|---|
| D009173 | Mycophenolic Acid |
| ID | Term |
|---|---|
| D002208 | Caproates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D005227 | Fatty Acids |
| D008055 | Lipids |
Not provided
Not provided